Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1.
@article{Viscidi1989InhibitionOA,
title={Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1.},
author={Raphael P. Viscidi and K Mayur and Howard M. Lederman and Alan D. Frankel},
journal={Science},
year={1989},
volume={246 4937},
pages={
1606-8
}
}The purified human immunodeficiency virus type-l (HIV-l) Tat protein inhibited lymphocyte proliferation induced by tetanus toxoid or Candida antigens by 66 to 97% at nanomolar concentrations of Tat. In contrast, Tat did not cause a significant reduction of lymphocyte proliferation in response to mitogens such as phytohemagglutinin or pokeweed mitogen. Inhibition was blocked by oxidation of the cysteine-rich region of Tat or by incubation with an antibody to Tat before the assay. A synthetic Tat…
282 Citations
Human immunodeficiency virus Tat induces functional unresponsiveness in T cells
- BiologyJournal of virology
- 1995
It is demonstrated that the mechanism of the Tat-mediated inhibition of T-cell functions involves a phospholipase C gamma 1-independent pathway.
Effects of HIV‐1 Tat protein on human T cell proliferation
- BiologyEuropean journal of immunology
- 1992
Results do not imply an important role for immunosuppressive effects of Tat in induction of immunodeficiency as observed in HIV infection in vivo, and no effect of Tat protein could be observed on T cell proliferative responses to recall antigen.
Cytotoxic effect on lymphocytes of Tat from human immunodeficiency virus (HIV‐1)
- BiologyFEBS letters
- 1993
HIV type 1 Tat protein inhibits interleukin 12 production by human peripheral blood mononuclear cells.
- BiologyAIDS research and human retroviruses
- 1998
The results suggest that Tat protein is one of the main causes of decreased IL-12 production by PBMCs (mostly by monocytes) from HIV-1-infected individuals.
Recombinant human immunodeficiency virus type 1 (HIV-1) Tat protein inhibits phagolysosomal fusion in human peripheral blood monocytes.
- BiologyViral immunology
- 1996
Results indicate the HIV-1 Tat protein can affect the monocyte microbicidal mechanisms at the phagolysosomal fusion step with little or not effect upon the lytic activity.
Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein.
- Biology, MedicineScience
- 1995
HIV-1 Tat protein was shown to induce cell death by apoptosis in a T cell line and in cultured peripheral blood mononuclear cells from uninfected donors, and was inhibitable by growth factors and was associated with enhanced activation of cyclin-dependent kinases.
The antigen-specific induction of normal human lymphocytes in vitro is down-regulated by a conserved HIV p24 epitope.
- Biology, MedicineImmunology letters
- 1992
Inhibition of HIV replication in acute and chronic infections in vitro by a Tat antagonist.
- Biology, MedicineScience
- 1991
The drug Ro 5-3335 inhibited gene expression by HIV-1 at the level of transcriptional trans-activation by Tat and its target sequence TAR, which reduced the amount of cell-associated viral RNA and antigen in acutely and in chronically infected cells in vitro.
Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS.
- Biology, MedicineProceedings of the National Academy of Sciences of the United States of America
- 1998
It is suggested that IFNalpha and Tat may be critical targets for anti-AIDS strategies because specific antibodies against these proteins prevent generation of suppressor cells in HIV-1-infected peripheral blood mononuclear cell cultures.
Human immunodeficiency virus type 1 Nef does not alter T-cell sensitivity to antigen-specific stimulation
- Biology, MedicineJournal of virology
- 1997
An in vitro model to study the influence that human immunodeficiency virus type 1 (HIV-1) may have on the ability of T cells to respond to antigenic challenge found no evidence for alteration of T-cell responsiveness to antigen by the gag, pol, vif, tat, or rev gene of HIV-1.
References
SHOWING 1-10 OF 16 REFERENCES
A quantitative bioassay for HIV-1 based on trans-activation.
- BiologyScience
- 1988
Isolates of simian immunodeficiency virus and human T cell lymphotropic virus type 4 activated these cells to a much lesser extent, which suggests that these viruses contain similar, but distinct, trans-activators.
CD4+ lymphocyte function with early human immunodeficiency virus infection.
- Biology, MedicineProceedings of the National Academy of Sciences of the United States of America
- 1989
Inhibition of proliferation to tetanus toxoid by gp120 suggests that HIV may affect major histocompatibility complex II restricted antigen recognition independent of CD4+ cell loss.
The trans-activator gene of the human T cell lymphotropic virus type III is required for replication
- BiologyCell
- 1986
Activity of synthetic peptides from the Tat protein of human immunodeficiency virus type 1.
- Biology, ChemistryProceedings of the National Academy of Sciences of the United States of America
- 1989
To determine which of the 86 amino acids in the Tat protein of human immunodeficiency virus type 1 (HIV-1) are important for transactivation, peptides from Tat were synthesized and their activity was…
Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition.
- Biology, MedicineThe New England journal of medicine
- 1985
The lymphocytes of patients with AIDS, although capable of undergoing a normal degree of blast transformation and lymphokine production after mitogenic stimulation, have an intrinsic defect in their ability to recognize and respond to soluble antigen.
The human immunodeficiency virus: infectivity and mechanisms of pathogenesis.
- Medicine, BiologyScience
- 1988
Infection with the human immunodeficiency virus (HIV) results in a profound immunosuppression due predominantly to a selective depletion of helper/inducer T lymphocytes that express the receptor for…
Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat.
- BiologyScience
- 1985
It is shown that, in human T-cell lines infected with HTLV-III, gene expression directed by the long terminal repeat sequence of this virus is stimulated by more than two orders of magnitude compared to matched uninfected cells.
Dimerization of the tat protein from human immunodeficiency virus: a cysteine-rich peptide mimics the normal metal-linked dimer interface.
- Biology, ChemistryProceedings of the National Academy of Sciences of the United States of America
- 1988
An 18-amino acid peptide that contains the cysteine-rich region of the tat protein from human immunodeficiency virus is synthesized, and mass spectrometry demonstrates that this peptide forms metal-linked dimers.
The trans-activator gene of HTLV-III is essential for virus replication
- BiologyNature
- 1986
It is shown that derivatives of a biologically competent molecular clone of HTLV-III, in which the tat-Ill gene is deleted or the normal splicing abrogated, failed to produce or expressed unusually low levels of virus, respectively, when transfected into T-cell cultures.